We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AzurRx BioPharma Inc | NASDAQ:AZRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.45 | 3.41 | 3.51 | 0 | 01:00:00 |
Delaware
|
001-37853
|
46-4993860
|
(State or Other
Jurisdiction of
Incorporation or
Organization)
|
(Commission File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
760 Parkside Avenue
Downstate Biotechnology Incubator,
Suite 304
Brooklyn, New York
|
|
11226
|
(Address of
principal executive offices)
|
|
(Zip
Code)
|
|
AzurRx BioPharma, Inc
.
|
|
|
|
|
|
|
Date: May 20,
2019
|
By:
|
/s/ Johan M.
Spoor
|
|
|
|
Name: Johan M. Spoor
|
|
|
|
Title: Chief Executive Officer
|
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
Press Release issued
by AzurRx BioPharma, Inc., dated May 20, 2019
|
1 Year AzurRx BioPharma Chart |
1 Month AzurRx BioPharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions